Description: Rekah Pharmaceutical Industry Ltd. engages in the manufacture, marketing, sale, and distribution of prescription and OTC drugs, dermo-cosmetics, vitamins, and nutritional supplements in Israel. The company offers steroid tablets; antibiotics, including penicillin and cephalosporin; drops and ointments to treat allergies, infections, and dryness of the eyes; dermatological preparations; baby products; and vitamins and nutritional supplements. Its portfolio of products comprise approximately 280 drugs used in various medical fields. The company was founded in 1941 and is based in Holon, Israel.
Home Page: www.rekah.co.il
30 Hamelach Street
Holon,
5881904
Israel
Phone:
972 3 558 1233
Officers
| Name | Title |
|---|---|
| Mr. Mordechai Elgrabli | CEO & Director |
| Mr. Yuval Bernshtein CPA | Chief Financial Officer |
| Ms. Georgette Elgrabli | Director of Industrial Division & Director |
| Mr. Jacob Elgrably | Chief Exec. Officer of Ophir Shalpharm |
| Mr. Meir Melumad | Director of Operations |
| Mr. Chaim Cohen | Chief Accounting Officer |
| Mr. Yuval Elgrabli | Deputy CEO & Director of Bus. Devel. |
| Mr. Yaakov Elgrabli | Chief Exec. Officer of Ophir & Shalpharm Ltd |
| Dr. Jack Azran | Chief Exec. Officer of RITE - Devel. and Technologies |
Exchange: TA
Country: IL
Currency: Israeli Agora (ILA)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 50 |
| Price-to-Book MRQ: | 1.1129 |
| Price-to-Sales TTM: | 0.6286 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 399 |